Cecilia Chung
Research Subjects
Research Interests
Cecilia Chung has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Alice Welbourn
Salamander Trust, London, UK
2 shared publications - Martha Tholanah
Making Waves Network, London
2 shared publications - Sophie Strachan
Sophia Forum London UK
2 shared publications - Svitlana Moroz
Eurasian Women’s Network on AIDS, Tbilisi, Georgia
2 shared publications - Violeta Ross
Latin American & Caribbean Movement of Positive Women, Asunción, Paraguay
2 shared publications Aleksandra Volgina
Global Network of People Living with HIV, Amsterdam, Netherlands
1 shared publication
Latest Publications
- 25 July 2025
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 18 (3)
HIV Data and Public Health Ethics
Uses of clinical data about people living with HIV (PLHIV) in US public health programs have expanded during the 2010–2020s. The digitization of the healthcare system and recognition that PLHIV who are virally suppressed cannot transmit have contributed to policy mandates for health departments to use routinely collected clinical HIV data to identify PLHIV who have fallen out of care—or who may be in transmission networks—and then (re-)link them to care. The ethics of these programs have been a source of controversy among bioethics scholars, social scientists, PLHIV networks, civil society actors, and others. Debates have focused on privacy and confidentiality, criminalization, community and stakeholder engagement, consent, and programs’ evidence base. The fundamental ethical question is: if clinical HIV data are collected for the benefit of individual patients, does the fact that those data can potentially benefit population health mean that they ought to be used for public health action? In our view, programs that utilize routinely collected clinical HIV data for public health purposes have inadequately accounted for ethical dilemmas raised by infrastructural transformations, biomedical advances, and policy shifts. We propose engaging stakeholders in an ethical reset to shape future developments regarding HIV data and public health.
- 25 July 2025
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 18 (3)
HIV Data and Public Health Ethics
Uses of clinical data about people living with HIV (PLHIV) in US public health programs have expanded during the 2010–2020s. The digitization of the healthcare system and recognition that PLHIV who are virally suppressed cannot transmit have contributed to policy mandates for health departments to use routinely collected clinical HIV data to identify PLHIV who have fallen out of care—or who may be in transmission networks—and then (re-)link them to care. The ethics of these programs have been a source of controversy among bioethics scholars, social scientists, PLHIV networks, civil society actors, and others. Debates have focused on privacy and confidentiality, criminalization, community and stakeholder engagement, consent, and programs’ evidence base. The fundamental ethical question is: if clinical HIV data are collected for the benefit of individual patients, does the fact that those data can potentially benefit population health mean that they ought to be used for public health action? In our view, programs that utilize routinely collected clinical HIV data for public health purposes have inadequately accounted for ethical dilemmas raised by infrastructural transformations, biomedical advances, and policy shifts. We propose engaging stakeholders in an ethical reset to shape future developments regarding HIV data and public health.
- Open Access
- 1 January 2022
- Published by SAGE Publications in Women's Health
- Vol. 18
What will it take to achieve the sexual and reproductive health and rights of women living with HIV?
This article outlines progress in realizing the sexual and reproductive health and rights of women and girls living with HIV over the last 30 years from the perspective of women living with HIV. It argues that the HIV response needs to go beyond the bio-medical aspects of HIV to achieve our sexual and reproductive health and rights, and considers relevant Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization, United States President’s Emergency Plan for AIDS Relief (PEPFAR), Global Fund and other guidelines, what engagement there has been with women living with HIV and whether guidelines/strategies have been adopted. It has been written by women living with HIV from around the world and a few key supporters. Co-authors have sought to collate and cite materials produced by women living with HIV from around the world, in the first known effort to date to do this, as a convergence of evidence to substantiate the points made in the article. However, as the article also argues, research led by women living with HIV is seldom funded and rarely accepted as evidence. Combined with a lack of meaningful involvement of women living with HIV in others’ research on us, this means that formally recognized evidence from women’s own perspectives is patchy at best. The article argues that this research gap, combined with the ongoing primacy of conventional research methods and topics that exclude those most affected by issues, and the lack of political will (and sometimes outright opposition) in relation to gender equality and human rights, adversely affect policies and programmes in relation to women’s rights. Thus, efforts to achieve an ethical, effective and sustainable response to the pandemic are hindered. The article concludes with a call to action to all key stakeholders.
- 1 January 2022
- Published by SAGE Publications in Women's Health
- Vol. 18
Open AccessWhat will it take to achieve the sexual and reproductive health and rights of women living with HIV?
This article outlines progress in realizing the sexual and reproductive health and rights of women and girls living with HIV over the last 30 years from the perspective of women living with HIV. It argues that the HIV response needs to go beyond the bio-medical aspects of HIV to achieve our sexual and reproductive health and rights, and considers relevant Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization, United States President’s Emergency Plan for AIDS Relief (PEPFAR), Global Fund and other guidelines, what engagement there has been with women living with HIV and whether guidelines/strategies have been adopted. It has been written by women living with HIV from around the world and a few key supporters. Co-authors have sought to collate and cite materials produced by women living with HIV from around the world, in the first known effort to date to do this, as a convergence of evidence to substantiate the points made in the article. However, as the article also argues, research led by women living with HIV is seldom funded and rarely accepted as evidence. Combined with a lack of meaningful involvement of women living with HIV in others’ research on us, this means that formally recognized evidence from women’s own perspectives is patchy at best. The article argues that this research gap, combined with the ongoing primacy of conventional research methods and topics that exclude those most affected by issues, and the lack of political will (and sometimes outright opposition) in relation to gender equality and human rights, adversely affect policies and programmes in relation to women’s rights. Thus, efforts to achieve an ethical, effective and sustainable response to the pandemic are hindered. The article concludes with a call to action to all key stakeholders.
- Open Access
- 18 July 2018
- Published by Elsevier in The Lancet Global Health
- Vol. 6 (10) , e1064-e1065
Time to realise our sexual and reproductive health and rights
- 18 July 2018
- Published by Elsevier in The Lancet Global Health
- Vol. 6 (10) , e1064-e1065
Open AccessTime to realise our sexual and reproductive health and rights